Related references
Note: Only part of the references are listed.A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease
Gunnar Brinkmalm et al.
PROTEOMICS CLINICAL APPLICATIONS (2018)
UniProt: the universal protein knowledgebase (vol 45, pg D158, 2017)
Alexandre Renaux
NUCLEIC ACIDS RESEARCH (2018)
Presymptomatic white matter integrity loss in familial frontotemporal dementia in the GENFI cohort: A cross-sectional diffusion tensor imaging study
Lize C. Jiskoot et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
Imaging and fluid biomarkers in frontotemporal dementia
Lieke H. Meeter et al.
NATURE REVIEWS NEUROLOGY (2017)
The mystery behind membrane insertion: a review of the complement membrane attack complex
Charles Bayly-Jones et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2017)
A multivariate predictive modeling approach reveals a novel CSF peptide signature for both Alzheimer's Disease state classification and for predicting future disease progression
Daniel A. Llano et al.
PLOS ONE (2017)
Pathophysiologic changes in IA-2/IA-2β null mice are secondary to alterations in the secretion of hormones and neurotransmitters
Tao Cai et al.
ACTA DIABETOLOGICA (2016)
2016 update of the PRIDE database and its related tools
Juan Antonio Vizcaino et al.
NUCLEIC ACIDS RESEARCH (2016)
Proteomics as an innovative tool to investigate frontotemporal disorders
Anna Maria Agresta et al.
PROTEOMICS CLINICAL APPLICATIONS (2016)
Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation
Hansen Lui et al.
CELL (2016)
Neurofilament light chain: a biomarker for genetic frontotemporal dementia
Lieke H. Meeter et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Progranulin Levels in Plasma and Cerebrospinal Fluid in Granulin Mutation Carriers
Lieke H. H. Meeter et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA (2016)
Cerebrospinal fluid proteomics and protein biomarkers in frontotemporal lobar degeneration: Current status and future perspectives
Patrick Oeckl et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis
Jonathan D. Rohrer et al.
LANCET NEUROLOGY (2015)
Depletion of highly abundant proteins from human cerebrospinal fluid: a cautionary note
Ramona Guenther et al.
MOLECULAR NEURODEGENERATION (2015)
Synaptic dysfunction and septin protein family members in neurodegenerative diseases
Mikael Marttinen et al.
MOLECULAR NEURODEGENERATION (2015)
Review: An update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations
T. Lashley et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2015)
High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer's Disease in Human Cerebrospinal Fluid
Ronald C. Hendrickson et al.
PLOS ONE (2015)
Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF
Daniel S. Spellman et al.
PROTEOMICS CLINICAL APPLICATIONS (2015)
Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics
Kristin R. Wildsmith et al.
MOLECULAR NEURODEGENERATION (2014)
Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia
Elise G. P. Dopper et al.
NEUROLOGY (2014)
Progranulin in neurodegenerative disease
Terri L. Petkau et al.
TRENDS IN NEUROSCIENCES (2014)
Innate immune activation in neurodegenerative disease
Michael T. Heneka et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Effects of Natalizumab Treatment on the Cerebrospinal Fluid Proteome of Multiple Sclerosis Patients
Marcel P. Stoop et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Pentraxins and Alzheimer's disease: At the interface between biomarkers and pharmacological targets
Cecilia Osera et al.
AGEING RESEARCH REVIEWS (2012)
Proteomic Changes in Cerebrospinal Fluid of Presymptomatic and Affected Persons Carrying Familial Alzheimer Disease Mutations
John M. Ringman et al.
ARCHIVES OF NEUROLOGY (2012)
A cross-platform toolkit for mass spectrometry and proteomics
Matthew C. Chambers et al.
NATURE BIOTECHNOLOGY (2012)
Synaptic dysfunction in progranulin-deficient mice
Terri L. Petkau et al.
NEUROBIOLOGY OF DISEASE (2012)
The Extended Granin Family: Structure, Function, and Biomedical Implications
Alessandro Bartolomucci et al.
ENDOCRINE REVIEWS (2011)
Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review
Harro Seelaar et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Progranulin Deficiency Decreases Gross Neural Connectivity But Enhances Transmission at Individual Synapses
Lucia Tapia et al.
JOURNAL OF NEUROSCIENCE (2011)
Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
Brendan MacLean et al.
BIOINFORMATICS (2010)
Estimating false discovery rates for peptide and protein identification using randomized databases
Gregory Hather et al.
PROTEOMICS (2010)
Serum Biomarker for Progranulin-Associated Frontotemporal Lobar Degeneration
Kristel Sleegers et al.
ANNALS OF NEUROLOGY (2009)
Neuroendocrine regulatory peptide-1 and-2: Novel bioactive peptides processed from VGF
K. Toshinai et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration
R. Ghidoni et al.
NEUROLOGY (2008)
A statistical model for identifying proteins by tandem mass spectrometry
AI Nesvizhskii et al.
ANALYTICAL CHEMISTRY (2003)
Share Paper
